DETERMARX
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88983793
- Registration number
- 6680289
- Mark type
- Stylized text
- Filed
- 06 Nov 2019
- Published for opposition
- 02 Jun 2020
- Registered
- 22 Mar 2022
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 010 — Medical apparatus: Biopsy tests and devices, namely, medical instruments for use in performing tissue biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; medical testing device for diagnosing cancer and detecting bioloigical traits that effect the risk of reoccurrence; medical testing devices for tumor diagnosis
Owner
- Oncocyte Corporation, Irvine, CA, US
- Oncocyte Corporation, Irvine, CA, US
- OncoCyte Corporation, Alameda, CA, US
Prosecution history
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 18 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jan 2022 — USE AMENDMENT FILED
- 08 Feb 2022 — DIVISIONAL PROCESSING COMPLETE
- 28 Jan 2022 — DIVISIONAL REQUEST RECEIVED
- 08 Feb 2022 — SOU EXTENSION 3 GRANTED
- 28 Jan 2022 — SOU EXTENSION 3 FILED
- 28 Jan 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 28 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 28 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 29 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2021 — SOU EXTENSION 2 GRANTED